Detect is a company headquartered in the United States.
Detect develops a scalable point-of-care molecular diagnostic platform aimed at delivering rapid, high-performance tests, initially focusing on women's health diagnostics and infectious diseases such as COVID-19.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.